Cognition Therapeutics (CGTX) Institutional Ownership $0.46 -0.05 (-9.78%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cognition Therapeutics (NASDAQ:CGTX)CurrentInstitutional OwnershipPercentage43.35%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$2.45MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$2.80M Get CGTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cognition Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CGTX Institutional Buying and Selling by Quarter Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Cognition Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/4/2024 Sigma Planning Corp197,190$92K0.0%+14.6%0.491% 8/12/2024 Mercer Global Advisors Inc. ADV95,951$159K0.0%+33.4%0.240% 8/9/2024 Renaissance Technologies LLC89,718$149K0.0%-42.4%0.224% 8/7/2024 AIGH Capital Management LLC300,766$499K0.2%-84.1%0.751% 8/2/2024 CM Management LLC200,000$332K0.3%+14.3%0.499% 7/16/2024 Bangor Savings Bank34,019$56K0.0%+41.6%0.085% Get the Latest News and Ratings for CGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2024 Levin Capital Strategies L.P.30,000$55K0.0%N/A0.075% 5/16/2024 AWM Investment Company Inc.650,000$1.18M0.2%N/A1.623% 5/14/2024 Carlson Capital L P213,995$389K0.0%-10.1%0.534% 5/14/2024 CM Management LLC175,000$318K0.3%N/A0.437% 5/10/2024 Tocqueville Asset Management L.P.26,000$47K0.0%N/A0.065% 5/8/2024Hohimer Wealth Management LLC225,000$410K0.1%N/A0.562% 3/5/2024 Twin Focus Capital Partners LLC93,372$173K0.0%N/A0.291% 2/8/2024 Texas Capital Bank Wealth Management Services Inc55,395$102K0.0%N/A0.172% 2/1/2024 Sigma Planning Corp28,550$53K0.0%N/A0.089% 10/23/2023Steward Financial Group LLC40,874$58K0.0%N/A0.135% 7/28/2023 Voss Capital LLC60,222$110K0.0%-62.4%0.206% 5/12/2023 Voss Capital LLC159,973$317K0.0%-4.2%0.546% 5/12/2023 FCA Corp TX51,471$102K0.0%N/A0.176% 2/16/2023 AIGH Capital Management LLC2,037,853$4.28M1.4%+155.3%7.030% 2/13/2023Northeast Financial Consultants Inc24,500$51K0.0%N/A0.085% 2/13/2023 Voss Capital LLC166,903$350K0.1%-23.8%0.576% 2/13/2023Financial Partners Capital Management LLC14,228$30K0.0%N/A0.049% 2/7/2023Commonwealth Equity Services LLC189,307$397K0.0%-13.6%0.653% 2/6/2023 Neumann Capital Management LLC33,382$70K0.0%N/A0.115% 1/31/2023 Kestra Advisory Services LLC50,618$106K0.0%+237.5%0.175% 1/20/2023 Diligent Investors LLC20,000$42K0.0%-34.5%0.069% 12/13/2022 Perigon Wealth Management LLC36,900$70K0.0%-70.0%0.127% 11/15/2022 Carlson Capital L P100,000$190K0.0%N/A0.440% 11/14/2022 Worth Venture Partners LLC200,188$380K0.2%-12.3%0.881% 11/10/2022 Rock Creek Group LP50,000$95K0.0%-37.3%0.220% 11/2/2022 Voss Capital LLC219,100$416K0.1%-29.2%0.965% 11/1/2022 P.A.W. Capital Corp100,000$190K0.3%-25.9%0.440% 10/12/2022Wealth Alliance Advisory Group LLC18,500$35K0.0%N/A0.081% 8/13/2022 Voss Capital LLC309,472$653K0.2%+1,070.5%1.363% 8/13/2022 Prosight Management LP120,198$254K0.2%-49.9%0.532% 8/11/2022 Perigon Wealth Management LLC122,846$259K0.0%N/A0.544% 8/8/2022 Rock Creek Group LP79,751$170K0.0%+201.6%0.353% 8/1/2022 Castle Wealth Management LLC43,380$92K0.1%N/A0.192% 7/19/2022Commonwealth Equity Services LLC214,961$453K0.0%+1,447.6%0.951% The Crypto That’s Making Wall Street Sweat (Ad)The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth7/13/2022 P.A.W. Capital Corp135,000$285K0.4%+12.5%0.597% 5/17/2022 Prosight Management LP240,080$660K0.4%-20.5%1.062% 5/4/2022Commonwealth Equity Services LLC13,890$38K0.0%N/A0.061% 4/26/2022 Diligent Investors LLC30,520$84K0.0%N/A0.135% 4/26/2022 Kestra Advisory Services LLC238,666$656K0.0%+150.9%1.057% 4/21/2022 P.A.W. Capital Corp120,000$330K0.3%+20.0%0.531% 4/14/2022 Bangor Savings Bank18,496$51K0.0%N/A0.082% 2/10/2022 B. Riley Financial Inc.30,904$195K0.0%N/A0.140% 2/10/2022 American Financial Group Inc.205,000$1.30M0.4%N/A0.930% 2/10/2022 AIGH Capital Management LLC25,496$161K0.0%N/A0.116% 2/10/2022 P.A.W. Capital Corp100,000$632K0.6%N/A0.454% (Data available from 1/1/2016 forward) CGTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGTX shares? During the previous two years, 23 institutional investors and hedge funds held shares of Cognition Therapeutics. The most heavily invested institutionals were AWM Investment Company Inc. ($1.18M), AIGH Capital Management LLC ($499K), Hohimer Wealth Management LLC ($410K), Commonwealth Equity Services LLC ($397K), Carlson Capital L P ($389K), CM Management LLC ($332K), and Twin Focus Capital Partners LLC ($173K).Learn more on CGTX's institutional investors. What percentage of Cognition Therapeutics stock is owned by institutional investors? 43.35% of Cognition Therapeutics stock is owned by institutional investors. Learn more on CGTX's institutional investor holdings. Which institutional investors have been buying Cognition Therapeutics stock? Of the 17 institutional investors that purchased Cognition Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($1.24M), AWM Investment Company Inc. ($650K), Hohimer Wealth Management LLC ($225K), CM Management LLC ($200K), Twin Focus Capital Partners LLC ($93.37K), Texas Capital Bank Wealth Management Services Inc ($55.40K), and Sigma Planning Corp ($53.60K). How much institutional buying is happening at Cognition Therapeutics? Institutional investors have bought a total of 2,807,008 shares in the last 24 months. This purchase volume represents approximately $5.44M in transactions. Which Cognition Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cognition Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($1.60M), Voss Capital LLC ($158.88K), Perigon Wealth Management LLC ($85.95K), Renaissance Technologies LLC ($65.98K), Commonwealth Equity Services LLC ($29.76K), Carlson Capital L P ($24.01K), and Diligent Investors LLC ($10.52K). How much institutional selling is happening at Cognition Therapeutics? Institutional investors have sold a total of 1,971,600 shares in the last 24 months. This volume of shares sold represents approximately $3.36M in transactions. Related Companies Bolt Biotherapeutics Institutional Ownership MiNK Therapeutics Institutional Ownership Avalo Therapeutics Institutional Ownership Daré Bioscience Institutional Ownership Elevation Oncology Institutional Ownership SCYNEXIS Institutional Ownership Oramed Pharmaceuticals Institutional Ownership Coherus BioSciences Institutional Ownership Cidara Therapeutics Institutional Ownership Werewolf Therapeutics Institutional Ownership This page (NASDAQ:CGTX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognition Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cognition Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
